| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/28/1999 | CA2296366A1 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 01/28/1999 | CA2296356A1 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 01/28/1999 | CA2296319A1 Lentiviral vectors |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2295719A1 Trail receptor |
| 01/28/1999 | CA2294518A1 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/28/1999 | CA2286357A1 Antacid and papain combination |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893691A1 Methods for diagnosis and therapy of autoimmunedisease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 01/27/1999 | EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/27/1999 | EP0893505A2 Novel glucose kinase |
| 01/27/1999 | EP0893504A1 Polypeptide coded by the Kaposi sarcoma-associated virus (KSHV, HHV-8) and its uses in diagnostic and therapy |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893502A2 GreA from Staphylococcus aureus |
| 01/27/1999 | EP0893501A2 Ferrichrome transport atp-binding protein |
| 01/27/1999 | EP0893500A2 BmrU gene from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0893449A1 Antitumor substance extracted from hen-of-the-woods |
| 01/27/1999 | EP0893439A1 Polypeptides modified by carbonates of polyalkylene oxide polymers |
| 01/27/1999 | EP0893069A2 Antioxidant composition containing a concentrate of sweet whey |
| 01/27/1999 | EP0892854A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 01/27/1999 | EP0892852A2 Cytochrome p450 transducing retroviral vectors |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892812A2 Agonist peptide dimers |
| 01/27/1999 | EP0892811A2 Peptides with antiproliferative properties |
| 01/27/1999 | EP0892809A1 Fhit proteins and nucleic acids and methods based thereon |
| 01/27/1999 | EP0892807A1 Gene family associated with neurosensory defects |
| 01/27/1999 | EP0892644A1 $i(IN VIVO) GENE TRANSFER METHODS FOR WOUND HEALING |
| 01/27/1999 | EP0892643A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 01/27/1999 | EP0892640A2 Enteric-coated pharmaceutical compositions of mycophenolate |
| 01/27/1999 | EP0765339B1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors |
| 01/27/1999 | EP0658198B1 Multicistronic expression units and their use |
| 01/27/1999 | EP0558671B1 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
| 01/27/1999 | EP0554441B1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 01/27/1999 | EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/27/1999 | EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine |
| 01/27/1999 | CN1206458A Ceramic packing with channels for thermal and catalytic beds |
| 01/27/1999 | CN1206423A Peptide derivatives of Dolastatin 15 and their use |
| 01/27/1999 | CN1206422A Growth-hormone secretagogues |
| 01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1205896A Interferon ointment and its preparation |
| 01/27/1999 | CN1041831C Neurotrophic factors having altered receptor binding specificities |
| 01/27/1999 | CN1041830C Peptide compound |
| 01/27/1999 | CN1041799C Preparation of thrombolytic composition |
| 01/27/1999 | CN1041794C Stabilized pharmaceutical composition comprising an. HMG-COA reductase inhibitor compound |
| 01/26/1999 | US5864029 Anti-sickling hemoglobin |
| 01/26/1999 | US5864028 Degradation resistant mRNA derivatives linked to TNF-α ribozymes |
| 01/26/1999 | US5864026 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 01/26/1999 | US5864024 Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis |
| 01/26/1999 | US5864021 Method and apparatus for the production of TGF-β and purified TGF-β compositions |
| 01/26/1999 | US5864020 A monoclonal antibody specifically binds to a hepatoma transmembrane kinase receptor ligand having selective amino acid sequence |
| 01/26/1999 | US5864019 Antigen-binding protein comprising: 3 or 4 vh domains; spacing polypeptide attached to c-terminal end of each vh domain; linkage polypeptide containing linkable residues attached to c-terminal end of each spacing polypeptide; vl domain |
| 01/26/1999 | US5864018 Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor |
| 01/26/1999 | US5864015 Hodgkin's disease associated molecules |
| 01/26/1999 | US5864012 Oligopeptides as antitumor agents |
| 01/26/1999 | US5864009 Including at least one nematode-extracted anticoagulant protein domain (?nap domain?), wherein said nap domain has an amino acid sequence having a molecular weight of about 8.7 to 8.8 kilodaltons, and contains ten cysteine amino acid residues |
| 01/26/1999 | US5863985 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 01/26/1999 | US5863955 Methods of using ajoene to inhibit an immune response |
| 01/26/1999 | US5863954 Contraceptive method using ajoene |
| 01/26/1999 | US5863950 Amides or thio amide compounds with hydroxy or ether groups |
| 01/26/1999 | US5863944 Compounds and compositions for delivering active agents |
| 01/26/1999 | US5863938 Wound healing agent comprises pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid and mixtures thereof; antioxidant; mixture of saturated and unsaturated fatty acids |
| 01/26/1999 | US5863937 Peptide conjugated compound as fungicides, bactericides, microbiocides treating candida albicans infection |
| 01/26/1999 | US5863929 Anticoagulant agents |
| 01/26/1999 | US5863906 Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863904 Methods for treating cancers and restenosis with P21 |
| 01/26/1999 | US5863902 Methods of treating neurodegenerative disorders using protease inhibitors |
| 01/26/1999 | US5863901 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders |
| 01/26/1999 | US5863900 Lhrh antagonists |
| 01/26/1999 | US5863899 Analgesics and antiinflammatory agent; a morphine or derivative is attached to brandykinin antagonist peptide by maleimido or amino acid analog linker |
| 01/26/1999 | US5863898 Human lim proteins |
| 01/26/1999 | US5863897 Synducin mediated modulation of tissue repair |
| 01/26/1999 | US5863896 Evaluation of substances for altering and for increasing APC response |
| 01/26/1999 | US5863894 Nematode-extracted anticoagulant protein |
| 01/26/1999 | US5863893 Anticoagulants |
| 01/26/1999 | US5863892 Use of platelet derived growth factor in ophthalmic wound healing |
| 01/26/1999 | US5863891 Protein fragments joined by peptide bonds |
| 01/26/1999 | US5863890 Smooth muscle relaxants; anticoagulants; vasodilation; protein regulation; cellular metabolism; blood oxygen transport |
| 01/26/1999 | US5863889 ICAM-1/LFA-1 short-chain peptides and method of using same |
| 01/26/1999 | US5863888 Human Bek Fibroblast growth factor receptor |
| 01/26/1999 | US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum |
| 01/26/1999 | US5863797 Gene fusion encoding a hypersecretor protein |
| 01/26/1999 | US5863796 Immunizing a mammal with specific polypeptide and collecting the antibody |
| 01/26/1999 | US5863795 Nucleic acids that encode peptides which modulate apoptosis |
| 01/26/1999 | US5863788 Recombinant L-methionine Y-lyase |
| 01/26/1999 | US5863786 Nucleic acid encoding modified human tnfα (tumor necrosis factor alpha) receptor |
| 01/26/1999 | US5863782 Enzymes and genetic sequences |
| 01/26/1999 | US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product |
| 01/26/1999 | US5863779 UBC7-like ubiquitin-conjugating enzyme |
| 01/26/1999 | US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine |
| 01/26/1999 | US5863775 Control of parasites |
| 01/26/1999 | US5863774 Cell ablation using trans-splicing ribozymes |
| 01/26/1999 | US5863769 DNA encoding interleukin-1 receptor antagonist (IL-1raβ) |